Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH)
2018 · PLoS ONE · 22 citations
https://doi.org/10.1371/journal.pone.0200996